A recent study has shown that AD and bacterial skin infection rates are higher in Indigenous youth compared to non-Indigenous youth.

Adult and pediatric AD patients have experienced more adverse effects after prolonged use of corticosteroids.

An early investigational report indicates that a compound derived from baby spinach leaves may be developed into an effective topical...

Tralokinumab treatment in patients with AD does not increase Covid-19 severity or interfere with Covid-19 vaccinations.

A digitally delivered intervention showed significant improvements in treatment adherence and other clinical outcomes in AD patients.

Sharing of the microbiome through skin contact between children with atopic dermatitis (AD) and their caregivers may contribute to...

Children with eczema between the ages of six months and six years benefit from treatment with dupilumab, according to the results of a...

New research has identified an immune biomarker in newborns that may predict the onset and severity of pediatric AD.